Asker Healthcare Group AB (OSTO:ASKER) EPS without NRI: kr1.55 (TTM As of Mar. 2026)


OSTO:ASKER Asker Healthcare Group AB OSTO:ASKER
13 GF Score
Price kr79.45
! 2 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB EPS without NRI?

Asker Healthcare Group AB OSTO:ASKER -1.30% 13 EPS without NRI is kr1.55 as of Mar. 2026. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 101 Medical Distribution companies, Asker Healthcare Group AB ranks worse than 55.45% on this metric.

Asker Healthcare Group AB's earnings per share without non-recurring items for the three months ended in Mar. 2026 was kr0.50. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55.

During the past 12 months, Asker Healthcare Group AB's average earnings per share (NRI) Growth Rate was 62.30% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 0.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Asker Healthcare Group AB's EPS without NRI or its related term are showing as below:

OSTO:ASKER' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0.1   Med: 0.1   Max: 0.1
Current: 0.1

During the past 4 years, Asker Healthcare Group AB's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 0.10% per year. The lowest was 0.10% per year. And the median was 0.10% per year.

OSTO:ASKER's 3-Year EPS without NRI Growth Rate is ranked worse than
55.45% of 101 companies
in the Medical Distribution industry
Industry Median: 2.6 vs OSTO:ASKER: 0.10

Asker Healthcare Group AB's EPS (Diluted) for the three months ended in Mar. 2026 was kr0.50. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55.

Asker Healthcare Group AB's EPS (Basic) for the three months ended in Mar. 2026 was kr0.50. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55.


Asker Healthcare Group AB  (OSTO:ASKER) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Asker Healthcare Group AB EPS without NRI Related Terms


Asker Healthcare Group AB EPS without NRI Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB EPS without NRI Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EPS without NRI
1.29 0.63 1.04 1.29

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.19 0.34 0.37 0.34 0.50

OSTO:ASKER vs MCK, CAH, COR: EPS without NRI Comparison

For the Medical Distribution subindustry, Asker Healthcare Group AB's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asker Healthcare Group AB PE Ratio without NRI vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Asker Healthcare Group AB's PE Ratio without NRI falls into.


OSTO:ASKER
13GF Score
Asker Healthcare Group AB OSTO:ASKER
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of kr1.55 mean?
Asker Healthcare Group AB (OSTO:ASKER) has a EPS without NRI of kr1.55 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Asker Healthcare Group AB and its competitors. According to the industry distribution chart, Asker Healthcare Group AB ranks #56 out of 101 companies in the Medical Distribution industry, placing it in the top 55.4%.
Is Asker Healthcare Group AB's EPS without NRI too high?
Asker Healthcare Group AB's current EPS without NRI is kr1.55. Based on the distribution chart, Asker Healthcare Group AB ranks #56 out of 101 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's EPS without NRI compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #56 out of 101 companies for EPS without NRI. This places Asker Healthcare Group AB in the lower half of its industry. The industry median EPS without NRI is 2.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 2.60, based on 101 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median EPS without NRI is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current EPS without NRI is kr1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current EPS without NRI of kr1.55. The current EPS without NRI is kr1.55. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current EPS without NRI is kr1.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKERs:UKI88:Germany
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score

Get the complete analysis for OSTO:ASKER

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr79.45
Price